Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. RNA Binding Protein Human Antigen R Is Translocated in Astrocytes following Spinal Cord Injury and Promotes the Inflammatory Response

RNA Binding Protein Human Antigen R Is Translocated in Astrocytes following Spinal Cord Injury and Promotes the Inflammatory Response

JOURNAL OF NEUROTRAUMA, 2017 · DOI: 10.1089/neu.2016.4757 · Published: March 15, 2017

Spinal Cord InjuryNeurologyGenetics

Simple Explanation

Inflammation is a key process after spinal cord injuries, driven by substances like TNF-α and IL-1β produced by brain cells called astrocytes and microglia. These substances are controlled by RNA binding proteins (RBPs), including human antigen R (HuR). This study found that after spinal cord injury in mice, HuR moves into the cytoplasm of astrocytes, suggesting it becomes active. Blocking HuR reduced the production of inflammatory substances by astrocytes and reduced their ability to attract other immune cells. Therefore, HuR could be a target for therapies to reduce inflammation and secondary tissue damage following CNS injuries.

Study Duration
Not specified
Participants
Female C57/Bl6 mice at 8–12 weeks of age
Evidence Level
Not specified

Key Findings

  • 1
    HuR translocates to the cytoplasm of astrocytes at the site of spinal cord injury, indicating its activation in response to the trauma.
  • 2
    Knockdown or chemical inhibition of HuR in astrocytes attenuates the induction of key inflammatory mediators, suggesting a role for HuR in promoting inflammation.
  • 3
    Inhibition of HuR impairs the ability of astrocytes to attract other immune cells, such as neutrophils and microglia, potentially reducing secondary tissue injury.

Research Summary

The study investigates the role of RNA-binding protein HuR in the inflammatory response following spinal cord injury (SCI). The research demonstrates that HuR is translocated to the cytoplasm in astrocytes after SCI, promoting the production of inflammatory mediators. Targeting HuR could be a potential therapeutic strategy to reduce secondary tissue injury in acute CNS trauma. The study uses both in vivo (mouse model of SCI) and in vitro (stretch injury model of astrocytes) experiments to support its conclusions.

Practical Implications

Therapeutic Target

HuR may be a therapeutic target for blunting secondary tissue injury triggered by the inflammatory response in acute CNS trauma.

Modulation of Inflammatory Response

HuR is a key modulator of the inflammatory response and may be a therapeutic target for reducing secondary tissue injury in early CNS trauma.

Drug Development

Development of drugs targeting HuR could potentially reduce the recruitment of immune cells and the production of cytokines, leading to less tissue damage.

Study Limitations

  • 1
    The in vitro assay does not fully recapitulate the microenvironment of an injured spinal cord.
  • 2
    The role of HuR will likely change during the course of CNS trauma, and the therapeutic effect of its inhibition may be limited to the early phases of injury.
  • 3
    The unexpected increase in TNF-a protein production following MS-444 treatment may reflect an off-target effect.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury